1.0 contact hour of continuing education (which includes 1.00 hour of pharmacology) by the American Association of Nurse Practitioners. Program ID 16032139.
This activity will address glycemic variability and cardiovascular considerations in patients with T2DM and examine therapeutic management, with a particular focus on the optimal use of GLP-1 receptor agonists and DPP-4 inhibitors.
*Learners will be redirected to the AANP website.
Developed by the American Association of Nurse Practitioners in cooperation with